(S)-2-amino-2-(2,6-difluorophenyl)ethan-1-ol, 98%, 1g

N-[(6-chloro-3-pyridinyl)methyl]acetamide, 95.0%, 250mg

9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene, 98.0%, 25g

3,6,9,12-Tetraoxatetradeca-1,13-diene, 97%, 1kg

4,5-DICHLORO-1,3-DIOXOLAN-2-ONE, 97.0%, 5g

Vial de reacción con brida plana, cilíndrico, graduado, con camisa protectora, pieza de conexión GL, DN 150, 4000 ml, 190 mm, 1 pieza

4-(4-Amino-3,5-dimethylbenzyl)-2,6-dimethylaniline, 95.0%, 5g

(R)-5-OXO-1-((R)-1-PHENYLETHYL)PYRROLIDINE-3-CARBOXYLIC ACID, 97.0%, 10g

2-(4-nitrophenoxy)acetamide, 1g

(3,4-Dibromophenyl)methanamine, 97%, 100mg

4-(2-Methyl-1,3-oxazol-4-yl)benzenesulfonyl chloride, 95.0%, 250mg

5-Bromo-2,3-difluorophenol, 98.0%, 500g

9,9-Dimethyl-9H-fluoren-2-ylboronic acid, 95.0%, 100g